[EN] NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF<br/>[FR] NOUVEAUX COMPOSES DE SPIROINDOLINE OU DE SPIROISOQUINOLINE, METHODES D'UTILISATION ET COMPOSITIONS ASSOCIEES
申请人:ARENA PHARM INC
公开号:WO2005063745A3
公开(公告)日:2006-03-16
CYCLOPROPYLAMINES FOR USE AS LSD1 INHIBITORS
申请人:Incyte Corporation
公开号:EP3626713B1
公开(公告)日:2021-09-29
[EN] CYCLOPROPYLAMINES AS LSD1 INHIBITORS<br/>[FR] CYCLOPROPYLAMINES EN TANT QU'INHIBITEURS DE LSD1
申请人:INCYTE CORP
公开号:WO2015123465A1
公开(公告)日:2015-08-20
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.